Anagrelide Hydrochloride Monohydrate is a tyrosine kinase inhibitor of the imidazoquinazolinone class, primarily indicated for the treatment of essential thrombocytosis in patients who have shown an inadequate… Read more
Anagrelide Hydrochloride Monohydrate is a tyrosine kinase inhibitor of the imidazoquinazolinone class, primarily indicated for the treatment of essential thrombocytosis in patients who have shown an inadequate response to other therapies. Beyond its role in managing elevated platelet counts, this compound has been explored in the clinical management of chronic myeloid leukemia. To support stringent quality control and regulatory compliance, pharmaceutical laboratories utilize high-quality reference standards of the active pharmaceutical ingredient, alongside its pharmacopeial and non-pharmacopeial impurities. These analytical tools, including metabolite markers and stable isotope-labelled compounds, are essential for robust impurity profiling, method validation, and pharmacokinetic studies. By facilitating precise identification and quantification of degradation products and metabolic pathways, these reference materials ensure the accuracy and reliability of analytical testing throughout the drug development and manufacturing lifecycle of this important hematological agent.